Literature DB >> 17143664

Clinical characteristics of Mycobacterium tuberculosis infection among rheumatoid arthritis patients.

Yasuhiko Yoshinaga1, Tatsuya Kanamori, Yusuke Ota, Tomoko Miyoshi, Hidetoshi Kagawa, Masahiro Yamamura.   

Abstract

To evaluate the clinical characteristics of Mycobacterium tuberculosis infection in rheumatoid arthritis (RA) patients, we examined the clinical manifestations and radiography/computed tomography (CT) findings in RA patients with tuberculosis (RA+/TB+). A total of 1121 tuberculosis patients were admitted to our hospital from 1995 to 2003, with the RA patients among them comprising 1.8% (20 cases; 9 men and 11 women). This is approximately three times as high as the prevalence of RA in the entire population in Japan. In addition, the RA+/TB+ patients were older and had a longer history of RA than the 140 outpatients in our RA clinic who did not have tuberculosis (RA+/TB-). Half of the RA+/TB+ patients had no symptoms (e.g., cough, sputum, pyrexia), and their tuberculosis was detected accidentally by radiography/CT. The positive rates of the bacilli in the smear and culture of the sputum from the RA+/TB+ patients were lower than those from 143 patients randomly selected from among 1091 tuberculosis patients without any collagen disease including RA (RA-/TB+). The RA+/TB+ patients had a higher incidence of extrapulmonary tuberculosis (30%), including four cases (20%) of miliary tuberculosis, an incidence seven times higher than among the general population of tuberculosis patients. Among 14 cases of pulmonary tuberculosis patients with RA, bilateral lesions and non-cavitary lesions were found in 71.4% and 64.3%, respectively, which tended to be a higher incidence than in the RA-/TB+ patients. The mortality rate and sputum conversion time of the RA+/TB+ patients were no different from those of the RA-/TB+ patients. The prevalence of tuberculosis in RA patients is expected to increase after introduction of anti-cytokine therapy in Japan, and careful observation should be done to avoid this complication in RA patients.

Entities:  

Year:  2004        PMID: 17143664     DOI: 10.1007/s10165-004-0281-x

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  6 in total

1.  A case of Poncet's disease (tuberculous rheumatism).

Authors:  Haruko Ideguchi; Shigeru Ohno; Kaoru Takase; Toshinori Tsukahara; Takeshi Kaneko; Yoshiaki Ishigatsubo
Journal:  Rheumatol Int       Date:  2008-12-03       Impact factor: 2.631

Review 2.  Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.

Authors:  Ethan Craig; Laura C Cappelli
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

3.  Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.

Authors:  Filip De Keyser
Journal:  Curr Rheumatol Rev       Date:  2011-02

4.  Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.

Authors:  Hyemin Jeong; Sun Young Baek; Seon Woo Kim; Yeong Hee Eun; In Young Kim; Hyungjin Kim; Jaejoon Lee; Eun-Mi Koh; Hoon-Suk Cha
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

5.  Therapeutic issues with, and long-term outcomes of, pulmonary mycobacterial tuberculosis treatment in patients with autoimmune rheumatic diseases.

Authors:  Dong Won Park; Sung Jun Chung; Yoomi Yeo; Tai Sun Park; Hyun Lee; Ji-Yong Moon; Sang-Heon Kim; Tae-Hyung Kim; Ho Joo Yoon; Jang Won Sohn
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

6.  Tuberculosis in people with rheumatic disease in Finland 1995-2007: a nationwide retrospective register study.

Authors:  Marjo Vuorela; Nina J Mars; Juha Salonen; Markku J Kauppi
Journal:  Rheumatol Adv Pract       Date:  2019-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.